Giacomo C Sturniolo
Overview
Explore the profile of Giacomo C Sturniolo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
840
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Banerjee A, Scarpa M, Pathak S, Burra P, Sturniolo G, Russo F, et al.
Endocr Metab Immune Disord Drug Targets
. 2019 Mar;
19(7):959-974.
PMID: 30864530
Background And Aims: Sexual functions are sometimes adversely affected by the therapeutic drugs delivered for treating IBD. Much attention has been focused on pregnancy/sexual issues in women. Relatively less attention...
2.
Heap G, So K, Weedon M, Edney N, Bewshea C, Singh A, et al.
J Crohns Colitis
. 2015 Dec;
10(2):149-58.
PMID: 26619893
Background And Aims: Nephrotoxicity is a rare idiosyncratic reaction to 5-aminosalicylate (5-ASA) therapies. The aims of this study were to describe the clinical features of this complication and identify clinically...
3.
Scarpa M, Martinato M, Bertin E, Da Roit A, Pozza A, Ruffolo C, et al.
Dig Surg
. 2015 May;
32(4):243-50.
PMID: 25997472
Purposes: Patients affected by Crohn's disease (CD) require lifelong medical therapy, but they can also often require abdominal surgery. The effect of CD therapy on postoperative course is still unclear....
4.
Monteleone G, Neurath M, Ardizzone S, Di Sabatino A, Fantini M, Castiglione F, et al.
N Engl J Med
. 2015 Mar;
372(12):1104-13.
PMID: 25785968
Background: Crohn's disease-related inflammation is characterized by reduced activity of the immunosuppressive cytokine transforming growth factor β1 (TGF-β1) due to high levels of SMAD7, an inhibitor of TGF-β1 signaling. Preclinical...
5.
Scarpa M, Brun P, Scarpa M, Morgan S, Porzionato A, Kotsafti A, et al.
Oncotarget
. 2015 Jan;
6(24):20058-69.
PMID: 25595911
In patients with ulcerative colitis (UC) the cumulative risk of colon cancer is lower than the actual rate of dysplasia suggesting an efficient immune surveillance mechanism. Since the co-stimulatory molecule...
6.
Heap G, Weedon M, Bewshea C, Singh A, Chen M, Satchwell J, et al.
Nat Genet
. 2014 Sep;
46(10):1131-4.
PMID: 25217962
Pancreatitis occurs in approximately 4% of patients treated with the thiopurines azathioprine or mercaptopurine. Its development is unpredictable and almost always leads to drug withdrawal. We identified patients with inflammatory...
7.
Cavallaro L, Monica F, Germana B, Marin R, Sturniolo G, Saia M
Dig Liver Dis
. 2013 Dec;
46(4):313-7.
PMID: 24365335
Background: Gastrointestinal bleeding is the most frequent emergency for gastroenterologists. Despite advances in management, an improvement in mortality is still not evident. Aim: Determining time trends of gastrointestinal bleeding hospitalization...
8.
Scarpa M, Cardin R, Bortolami M, Kotsafti A, Scarpa M, Pozza A, et al.
Eur J Cancer
. 2012 Jun;
49(1):254-63.
PMID: 22704122
Background: CD80 has been thought to play an active role in immunosurveillance as it has been found to be up-regulated in ulcerative colitis (UC) patients with dysplasia. The aim of...
9.
Scarpa M, Bortolami M, Cecchetto A, Faggian D, Kotsafti A, Ruffolo C, et al.
Eur J Cancer
. 2010 Nov;
47(4):611-9.
PMID: 21067914
Background: In patients with ulcerative colitis (UC) the inconsistency between the rate of dysplasia and actual cancer incidence suggests the presence of an immunosurveillance mechanism. The aim of our study...
10.
Ruffolo C, Scarpa M, Faggian D, Basso D, DInca R, Plebani M, et al.
J Gastrointest Surg
. 2009 Nov;
14(1):24-31.
PMID: 19902313
Background/aims: Fecal lactoferrin is the direct expression of intestinal inflammation in Crohn's disease (CD). The aim of this study was to analyze the in vivo intimate correlation between intestinal and...